Cogent Biosciences Inc

NASDAQ:COGT   3:59:43 PM EDT
9.83
0.00 (0.00%)
4:01:02 PM EDT: $9.65 -0.18 (-1.83%)
Earnings Announcements

Cogent Biosciences Reports Third Quarter 2020 Financial Results And Provides Corporate Updates

Published: 11/09/2020 12:23 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates.
Q3 Loss per Share $5.07.
Q3 Earnings per Share Estimate $-0.14 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Collaboration Revenue $$0.3mln Versus $1mln.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.